Best stock investments – Microblog: Regulus: Shares should double , maybe triple in the next six weeks !



Best stock investments

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

It has seemed to have been an eternity since the FDA placed rg-101 on a clinical hold. Regulus has stated they will provide a complete response letter to all of the questions and information requested by the FDA early in the fourth quarter 2016. The FDA then has thirty days to respond to the companies information provided. The FDA will either release the drug from clinical hold or request clarification of some of the information provided. That date I believe will be close to November 15th, 2016. It seems to me that based upon the scientific explanation provided by Dr. Kss, RGLS’s drug has nearly a 100% chance of the clinical hold being lifted on it. I can’t think of a better opportunity to take advantage of an almost certain thing. Certainly in the next six weeks there is no other stock in my portfolio that I think will double or even triple in value, unless maybe Akao is bought out or something else unusual happens. The only other potential news that could affect the stock price could be the releasing of the data from the trial of rg-101 with Gsk’s long acting drug NS5B. GSK holds out hope that the combination of these two drugs will cure the disease in a single office visit. Dr. Kss believes that this is doubtful as he believes a combination of three drugs combined is necessary. If the results are ineffective we could see another substantial drop in share price. However if the clinical hold is lifted a couple of weeks before the data with GSK comes out then Regulus’s shares should at least double. I plan in the next week to reduce almost all of my other stock positions and use the funds to buy RGLS stock. Long RGLS , AKAO . Wishing all gummies the best in the upcoming months as the year comes to a close.! Mark I would love to hear other peoples thoughts and ideas about this subject. In my heart I hope the GSK/RGLS combination achieves 100% cure rates and GILD and GSK get in a bidding war for RGLS!

– Best stock investments

Learn How To Be #1 on Google Results



Source link